TerminatedNCT05571267
Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
PHASE2 · 1 planned enrolment
- Countries listed
- 0
- Registry update
- March 13, 2025
Registry Intervention View
Eylea
Trial registrations containing the exact intervention label Eylea.
Exact registry label · Not reported
5 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
2 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT04058535
Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD
PHASE1 · 28 planned enrolment
- Countries listed
- 1
- Registry update
- January 20, 2022
UnknownNCT04572698
A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）
PHASE3 · 416 planned enrolment
- Countries listed
- 0
- Registry update
- October 1, 2020
CompletedNCT02732899
Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
PHASE2 · 20 planned enrolment
- Countries listed
- 1
- Registry update
- February 14, 2018
CompletedNCT02142296
Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
PHASE4 · 37 planned enrolment
- Countries listed
- 1
- Registry update
- February 16, 2017